Cargando…

Role of Ascertainment Bias in Determining Case Fatality Rate of COVID-19

Case fatality rate (CFR) is used to calculate mortality burden of COVID-19 under different scenarios, thus informing risk-benefit balance of interventions both pharmaceutical and nonpharmaceutical. However, observed CFR is driven by testing: as more low-risk cases are identified, observed CFR will d...

Descripción completa

Detalles Bibliográficos
Autor principal:	Smith, Maia P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Atlantis Press 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242115/ https://www.ncbi.nlm.nih.gov/pubmed/33876593 http://dx.doi.org/10.2991/jegh.k.210401.001

Ejemplares similares

Estimating infection fatality risk and ascertainment bias of COVID-19 in Osaka, Japan from February 2020 to January 2022
por: Zhang, Tong, et al.
Publicado: (2023)

Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines
por: Hourihane, Jonathan O’B., et al.
Publicado: (2021)

Sources of bias in COVID-19 infection fatality rate estimation
por: Pezzullo, AM
Publicado: (2022)

Ascertainment rate of novel coronavirus disease (COVID-19) in Japan
por: Omori, Ryosuke, et al.
Publicado: (2020)

Ascertainment bias from imputation methods evaluation in wheat
por: Brandariz, Sofía P., et al.
Publicado: (2016)

How array design creates SNP ascertainment bias
por: Geibel, Johannes, et al.
Publicado: (2021)

How imputation can mitigate SNP ascertainment Bias
por: Geibel, Johannes, et al.
Publicado: (2021)

Resolving kangaroo phylogeny and overcoming retrotransposon ascertainment bias
por: Dodt, William G., et al.
Publicado: (2017)

COVID-19 Clinical Bias, Persons with Disabilities, and Human Rights
por: Haque, Omar Sultan, et al.
Publicado: (2020)

Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud
por: Hill, Andrew, et al.
Publicado: (2022)

Determining the acceptability of testing contacts of confirmed COVID-19 cases to improve secondary case ascertainment
por: Marchant, E, et al.
Publicado: (2021)

Ascertainment bias in the genomic test of positive selection on regulatory sequences
por: Jiang, Daohan, et al.
Publicado: (2023)

Proposal for Tier-Based Resumption of Dental Practice Determined by COVID-19 Rate, Testing and COVID-19 Vaccination: A Narrative Perspective
por: Farshidfar, Nima, et al.
Publicado: (2021)

Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
por: Brown, Ronald B.
Publicado: (2021)

The Case for Intervention Bias in the Practice of Medicine
por: Foy, Andrew J., et al.
Publicado: (2013)

Determining the Case Fatality Rate of COVID-19 in Italy: Novel Epidemiological Study
por: Yan, Mengqing, et al.
Publicado: (2022)

Sex-Biased Vulnerability of the Heart to COVID-19
por: Ritter, Oliver, et al.
Publicado: (2020)

Detecting and Removing Ascertainment Bias in Microsatellites from the HGDP-CEPH Panel
por: Eriksson, Anders, et al.
Publicado: (2011)

Adjusting heterogeneous ascertainment bias for genetic association analysis with extended families
por: Park, Suyeon, et al.
Publicado: (2015)

Bias at warp speed: how AI may contribute to the disparities gap in the time of COVID-19
por: Röösli, Eliane, et al.
Publicado: (2020)

Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic
por: Oliveira J. e Silva, Lucas, et al.
Publicado: (2020)

Estimating case fatality rates of COVID-19
por: Kim, David Dongkyung, et al.
Publicado: (2020)

Estimating case fatality rates of COVID-19
por: Lipsitch, Marc
Publicado: (2020)

Estimating case fatality rates of COVID-19
por: Spychalski, Piotr, et al.
Publicado: (2020)

Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational COVID-19 studies
por: Bodner, Korryn, et al.
Publicado: (2023)

Does Sex Bias Play a Role for Dissatisfied Patients With Hypothyroidism?
por: McAninch, Elizabeth A, et al.
Publicado: (2018)

The Sick Bias
por: Arkfeld, Christopher Ke
Publicado: (2021)

Ascertainment Bias in a Historic Cohort Study of Residents in an Asbestos Manufacturing Community
por: Wortzel, Jeremy D., et al.
Publicado: (2021)

Impact of Marker Ascertainment Bias on Genomic Selection Accuracy and Estimates of Genetic Diversity
por: Heslot, Nicolas, et al.
Publicado: (2013)

Estimation of epidemiological parameters and ascertainment rate from early transmission of COVID-19 across Africa
por: Han, Qing, et al.
Publicado: (2023)

Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i)
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2021)

Recent Advances in Attention Bias Modification for Substance Addictions
por: Zhang, Melvyn Weibin, et al.
Publicado: (2018)

Discovery of novel variants in genotyping arrays improves genotype retention and reduces ascertainment bias
por: Didion, John P, et al.
Publicado: (2012)

Potential Selection Biases
por: Bornehag, Carl-Gustaf, et al.
Publicado: (2005)

Stem Cells and Metastatic Cancer: Fatal Attraction?
por: Fodde, Riccardo
Publicado: (2006)

National case fatality rates of the COVID-19 pandemic
por: Ergönül, Önder, et al.
Publicado: (2021)

The many estimates of the COVID-19 case fatality rate
por: Rajgor, Dimple D, et al.
Publicado: (2020)

Treatment and case fatality rate of COVID-19 in Africa
por: Bepouka, Ben, et al.
Publicado: (2022)

Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study
por: Kuwelker, Kanika, et al.
Publicado: (2021)

Risk factor studies of age-at-onset in a sample ascertained for Parkinson disease affected sibling pairs: a cautionary tale
por: Wilk, Jemma B, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_di4jd057vi2ss3h2bq5ertsl2f